Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users

被引:23
作者
Tucker, T
Fry, CL
Lintzeris, N
Baldwin, S
Ritter, A
Donath, S
Whelan, G
机构
[1] Turning Point Alcohol & Drug Ctr, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Publ Hlth, Parkville, Vic 3052, Australia
[3] Natl Addict Ctr, London, England
[4] Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia
[5] St Vincents Hosp, Melbourne, Vic, Australia
关键词
brief behavioural intervention; hepatitis C virus; injecting drug use; randomized controlled trial;
D O I
10.1111/j.1360-0443.2004.00809.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim To develop and evaluate a brief intervention for reducing risk behaviours associated with HCV transmission in injecting drug users (IDU). Design Randomized controlled trial of an individually tailored brief behavioural intervention (BBI) (experimental) versus a standardized educational intervention (control). Setting Specialist drug treatment facility in Melbourne, Australia. Participants One hundred and forty-five IDU (aged 18 or over, injecting at least weekly in the preceding 6 months) recruited and randomized to the experimental condition (n = 73) or the control condition (n = 72). Interventions The BBI was based on the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ)-a standardized blood-borne virus risk assessment instrument comprising injecting risk, sexual risk and other skin penetration risk subscales. The BBV-TRAQ was used to identify individual HCV risk practices and to tailor the 30-minute experimental BBI. Control participants received a standardized HCV educational session, using current educational materials. Main outcome measures BBV-TRAQ subscale and total scores and measures of participant satisfaction. Results One hundred and twenty-four participants (86%) were followed-up at 4 weeks ( 7 days). Analyses revealed a significant reduction in HCV risk behaviours for both groups at 1-month follow-up, with participants in the experimental BBI condition reporting higher overall satisfaction with the intervention compared to the control group. Conclusions Both groups reported significant reductions in risk behaviour, indicating that while BBI methods hold promise for HCV education and prevention, they were not demonstrated to be more effective than the provision of standard educational materials. Future research could evaluate the efficacy of the BBV-TRAQ as a risk behaviour intervention and counselling tool in clinical, NSP and peer education settings.
引用
收藏
页码:1157 / 1166
页数:10
相关论文
共 50 条
[31]   Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C [J].
Wright, NMJ ;
Tompkins, CNE ;
Jones, L .
HEALTH & SOCIAL CARE IN THE COMMUNITY, 2005, 13 (01) :75-83
[32]   Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria [J].
Crofts, N ;
Cooper, G ;
Stewart, T ;
Kiely, P ;
Coghlan, P ;
Hearne, P ;
Hocking, J .
JOURNAL OF VIRAL HEPATITIS, 1997, 4 (05) :333-338
[33]   New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users [J].
Kretzschmar, Mirjam ;
Wiessing, Lucas .
AIDS, 2008, 22 (13) :1527-1537
[34]   Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy [J].
Spada, Enea ;
Rezza, Giovanni ;
Garbuglia, Anna Rosa ;
Lombardo, Flavia Lucia ;
Zuccaro, Ornella ;
Ippolito, Francesca Menniti ;
Cupellaro, Elisabetta ;
Capone, Stefania ;
Capobianchi, Maria Rosaria ;
Nicosia, Alfredo ;
Cortese, Riccardo ;
Folgori, Antonella ;
Mele, Alfonso .
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2018, 95 (01) :99-110
[35]   Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy [J].
Enea Spada ;
Giovanni Rezza ;
Anna Rosa Garbuglia ;
Flavia Lucia Lombardo ;
Ornella Zuccaro ;
Francesca Menniti Ippolito ;
Elisabetta Cupellaro ;
Stefania Capone ;
Maria Rosaria Capobianchi ;
Alfredo Nicosia ;
Riccardo Cortese ;
Antonella Folgori ;
Alfonso Mele .
Journal of Urban Health, 2018, 95 :99-110
[36]   Hepatitis C Virus Infection and Related Risk Factors among Injection Drug Users in Montenegro [J].
Bacak, Valerio ;
Lausevic, Dragan ;
Mugosa, Boban ;
Vratnica, Zoran ;
Terzic, Natasa .
EUROPEAN ADDICTION RESEARCH, 2013, 19 (02) :68-73
[37]   Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001 [J].
Jarlais, DCD ;
Perlis, T ;
Arasteh, K ;
Torian, LV ;
Holly, HB ;
Beatrice, S ;
Smith, L ;
Wethers, J ;
Milliken, J ;
Mildvan, D ;
Yancovitz, S ;
Friedman, SR .
AIDS, 2005, 19 :S20-S25
[38]   The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam [J].
Matser, Amy ;
Urbanus, Anouk ;
Geskus, Ronald ;
Kretzschmar, Mirjam ;
Xiridou, Maria ;
Buster, Marcel ;
Coutinho, Roel ;
Prins, Maria .
ADDICTION, 2012, 107 (03) :614-623
[39]   Increased hepatitis C virus vaccine clinical trial literacy following a brief intervention among people who inject drugs [J].
White, Bethany ;
Madden, Annie ;
Hellard, Margaret ;
Kerr, Thomas ;
Prins, Maria ;
Page, Kimberly ;
Dore, Gregory J. ;
Maher, Lisa .
DRUG AND ALCOHOL REVIEW, 2013, 32 (04) :419-425
[40]   Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: Comparison with non-injecting drug users [J].
Basu, Debasish ;
Kumar, Vineet ;
Sharma, Arun Kumar ;
Barnwal, Pawan Kumar ;
Mattoo, Surendra Kumar .
ASIAN JOURNAL OF PSYCHIATRY, 2013, 6 (01) :52-55